These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 38988947)
1. Identification of tumor antigens for mRNA vaccines and ferroptosis-related landscape in esophageal squamous cell carcinoma. Zeng Q; Chen B; Wang W Transl Cancer Res; 2024 Jun; 13(6):2860-2876. PubMed ID: 38988947 [TBL] [Abstract][Full Text] [Related]
2. Identification of Tumor Antigens and Immune Subtypes of Esophageal Squamous Cell Carcinoma for mRNA Vaccine Development. Lu T; Xu R; Wang CH; Zhao JY; Peng B; Wang J; Zhang LY Front Genet; 2022; 13():853113. PubMed ID: 35734437 [No Abstract] [Full Text] [Related]
3. Identification of ferroptosis-associated tumor antigens as the potential targets to prevent head and neck squamous cell carcinoma. Zhai Q; Wang Z; Tang H; Hu S; Chen M; Ji P Genes Dis; 2024 Nov; 11(6):101212. PubMed ID: 39286654 [TBL] [Abstract][Full Text] [Related]
4. Identification of Lower Grade Glioma Antigens Based on Ferroptosis Status for mRNA Vaccine Development. Zhao Z; Xing N; Guo H; Li J; Sun G Pharmgenomics Pers Med; 2024; 17():105-123. PubMed ID: 38623558 [TBL] [Abstract][Full Text] [Related]
5. Discovery of lung adenocarcinoma tumor antigens and ferroptosis subtypes for developing mRNA vaccines. Chen Y; Zhang C; Li Y; Tan X; Li W; Tan S; Liu G Sci Rep; 2024 Feb; 14(1):3219. PubMed ID: 38331967 [TBL] [Abstract][Full Text] [Related]
6. Ferroptosis patterns and tumor microenvironment infiltration characterization in esophageal squamous cell cancer. Zhang LL; Zhu WJ; Zhang XX; Feng D; Wang XC; Ding Y; Wang DX; Li YY Front Genet; 2022; 13():1047382. PubMed ID: 36568375 [No Abstract] [Full Text] [Related]
7. Identification of immunity- and ferroptosis-related signature genes as potential design targets for mRNA vaccines in AML patients. Wang C; Lv L; Ma P; Zhang Y; Li M; Deng J; Zhang Y Aging (Albany NY); 2024 Aug; 16(16):11939-11954. PubMed ID: 39213256 [TBL] [Abstract][Full Text] [Related]
8. A risk prognostic model for patients with esophageal squamous cell carcinoma basing on cuproptosis and ferroptosis. Li J; Liu J; Li J; Feng A; Nie Y; Yang Z; Zhang W J Cancer Res Clin Oncol; 2023 Oct; 149(13):11647-11659. PubMed ID: 37405477 [TBL] [Abstract][Full Text] [Related]
9. Ferroptosis-Related lncRNA Signature Correlates with the Prognosis, Tumor Microenvironment, and Therapeutic Sensitivity of Esophageal Squamous Cell Carcinoma. Zhu J; Zhao Y; Wu G; Zhang X; Chen Q; Yang B; Guo X; Ji S; Gu K Oxid Med Cell Longev; 2022; 2022():7465880. PubMed ID: 35903713 [TBL] [Abstract][Full Text] [Related]
10. Discovering ferroptosis-associated tumor antigens and ferroptosis subtypes in pancreatic adenocarcinoma to facilitate mRNA vaccine development. Yan T; Wang L Heliyon; 2024 Mar; 10(5):e27194. PubMed ID: 38463885 [TBL] [Abstract][Full Text] [Related]
11. Development and Validation of a Ferroptosis-Related Gene Signature and Nomogram for Predicting the Prognosis of Esophageal Squamous Cell Carcinoma. Ye J; Wu Y; Cai H; Sun L; Deng W; Liang R; Han A Front Genet; 2021; 12():697524. PubMed ID: 34764976 [TBL] [Abstract][Full Text] [Related]
12. Identification of ferroptosis genes in immune infiltration and prognosis in thyroid papillary carcinoma using network analysis. Lin R; Fogarty CE; Ma B; Li H; Ni G; Liu X; Yuan J; Wang T BMC Genomics; 2021 Jul; 22(1):576. PubMed ID: 34315405 [TBL] [Abstract][Full Text] [Related]
13. Identification of Key Modules and Hub Genes Involved in Esophageal Squamous Cell Carcinoma Tumorigenesis Using WCGNA. Chen N; Zhang G; Fu J; Wu Q Cancer Control; 2020; 27(1):1073274820978817. PubMed ID: 33345608 [TBL] [Abstract][Full Text] [Related]
14. Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell Carcinoma. Guo W; Tan F; Huai Q; Wang Z; Shao F; Zhang G; Yang Z; Li R; Xue Q; Gao S; He J Front Immunol; 2021; 12():669750. PubMed ID: 34054840 [TBL] [Abstract][Full Text] [Related]
15. Identification and characterization of prognosis-related genes in the tumor microenvironment of esophageal squamous cell carcinoma. Qu J; Zhao Q; Yang L; Ping Y; Zhang K; Lei Q; Liu F; Zhang Y Int Immunopharmacol; 2021 Jul; 96():107616. PubMed ID: 34162127 [TBL] [Abstract][Full Text] [Related]
16. Identification of three tumor antigens and immune subtypes for mRNA vaccine development in diffuse glioma. Zhou Q; Yan X; Zhu H; Xin Z; Zhao J; Shen W; Yin W; Guo Y; Xu H; Zhao M; Liu W; Jiang X; Ren C Theranostics; 2021; 11(20):9775-9790. PubMed ID: 34815785 [No Abstract] [Full Text] [Related]
17. Dissection of tumor antigens and immune landscape in clear cell renal cell carcinoma: Preconditions for development and precision medicine of mRNA vaccine. Hu J; Mo Z Math Biosci Eng; 2023 Jan; 20(2):2157-2182. PubMed ID: 36899527 [TBL] [Abstract][Full Text] [Related]
18. Identification and analysis of a prognostic ferroptosis and iron-metabolism signature for esophageal squamous cell carcinoma. Zhao M; Li M; Zheng Y; Hu Z; Liang J; Bi G; Bian Y; Sui Q; Zhan C; Lin M; Wang Q J Cancer; 2022; 13(5):1611-1622. PubMed ID: 35371305 [No Abstract] [Full Text] [Related]
19. PLK1 regulating chemoradiotherapy sensitivity of esophageal squamous cell carcinoma through pentose phosphate pathway/ferroptosis. Zhao M; Lu T; Bi G; Hu Z; Liang J; Bian Y; Feng M; Zhan C Biomed Pharmacother; 2023 Dec; 168():115711. PubMed ID: 37879213 [TBL] [Abstract][Full Text] [Related]
20. Prognostic value and immune landscapes of cuproptosis-related lncRNAs in esophageal squamous cell carcinoma. Zhang X; Feng N; Wu B; Guo Z; Pan T; Tao X; Zheng H; Zhang W Aging (Albany NY); 2023 Oct; 15(19):10473-10500. PubMed ID: 37812189 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]